| Title: |
Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS) |
| Authors: |
Landgren, C. OlaAff1, IDs413750200718z_cor1; Chari, AjaiAff2; Cohen, Yael C.Aff3; Spencer, AndrewAff4; Voorhees, PeterAff5; Estell, Jane A.Aff6; Sandhu, IrwindeepAff7; Jenner, Matthew W.Aff8; Williams, CatherineAff9; Cavo, MicheleAff10; van de Donk, Niels W. C. J.Aff11; Beksac, MeralAff12; Moreau, PhilippeAff13; Goldschmidt, HartmutAff14; Kuppens, StevenAff15; Bandekar, RajeshAff16; Clemens, Pamela L.Aff16; Neff, TobiasAff16; Heuck, ChristophAff16; Qi, MingAff16; Hofmeister, Craig C.Aff17, IDs413750200718z_cor21 |
| Source: |
Leukemia. 34(7):1840-1852 |
| Database: |
Springer Nature Journals |